Koh H K, Clapp R W, Barnett J M, Nannery W M, Tahan S R, Geller A C, Bhawan J, Harrist T J, Kwan T, Stadecker M
Department of Dermatology, Boston University School of Medicine, MA 02118-2394.
J Am Acad Dermatol. 1991 Apr;24(4):545-50. doi: 10.1016/0190-9622(91)70079-h.
An independent tabulation of incidence of cutaneous malignant melanoma in Massachusetts indicates that 12% and perhaps as many as 19% of new cases of cutaneous malignant melanoma in Massachusetts are not recorded in the Massachusetts Cancer Registry, significantly more than the expected 5% (p = 0.0001). The increasing number of nonhospital medical settings in which melanomas can be diagnosed and/or treated appears to account for this discrepancy. We suspect that these findings in Massachusetts also apply to cancer reporting systems in other regions of the United States. We suggest that the true incidence of cutaneous malignant melanoma in Massachusetts, and perhaps in the United States, may be significantly higher than reported.
对马萨诸塞州皮肤恶性黑色素瘤发病率的一项独立统计表明，该州皮肤恶性黑色素瘤新发病例中有12%，甚至可能多达19%未被记录在马萨诸塞州癌症登记处，这一比例显著高于预期的5%（p = 0.0001）。黑色素瘤可被诊断和/或治疗的非医院医疗环境数量不断增加，似乎是造成这种差异的原因。我们怀疑马萨诸塞州的这些发现也适用于美国其他地区的癌症报告系统。我们认为，马萨诸塞州乃至美国皮肤恶性黑色素瘤的实际发病率可能远高于报告的数字。
